Prazer Therapeutics
Operator of a biotechnology company intended to develop novel therapeutics to treat a variety of refractory diseases. The company is focused on developing therapeutics for the treatment of neurodegene...
Valuation
$0
Share Price
N/A
Total Raised
$35.9M
Last Round
N/A